JAAPA CME Post-Test May 2016
Healing livers, saving lives: Hepatitis C screening in an era of cure. Recognizing, diagnosing, and treating rhabdomyolysis. Member Fee: $0   Nonmember Fee: $25

Healing Livers, Saving Lives: Hepatitis C Screening in an Era of Cure

Courtney M. Boucher, MPAP, PA-C; Anne Walsh, MMSc, PA-C, DFAAPA; Christopher P. Forest, MSHS, PA-C, DFAAPA

Chronic hepatitis C affects more than 3 million people in the United States. In the past, drug therapy with interferon and ribavirin resulted in low overall cure rates and early discontinuation due to adverse reactions. The new direct-acting antivirals offer not only a shorter duration of treatment with fewer adverse reactions, but greatly improved overall cure rates as high as 96%. Updated national screening recommendations (including a one-time screening for patients born between 1945 and 1965), combined with timely referral and treatment, offer a prime opportunity for healthcare providers to improve public health outcomes and reduce healthcare costs.

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Explain the hepatitis C screening guidelines relative to the likely epidemiologic causes for patients developing the disease.
  • Describe the laboratory and diagnostic screening tests recommended for patients with suspected hepatitis C.
  • Discuss updates to therapy options and management steps for patients with hepatitis C.

Recognizing, Diagnosing, and Treating Rhabdomyolysis

Henry Heard, MPAS, MA, PA-C; James Barker, MMSc, PA-C

Rhabdomyolysis is an acute and potentially fatal syndrome characterized by striated muscle breakdown and subsequent release of muscle cell contents into the systemic circulation. The sudden release of large quantities of potassium, calcium, organic acids, and myoglobin into the bloodstream can cause renal tubal toxicity, cardiac dysrhythmias, and death. Complications can be managed and minimized if predicted and treated early, but patients may not have classic symptoms of rhabdomyolysis and may even be asymptomatic on presentation. This activity reviews the pathophysiology, causes, diagnosis, and treatment of acute rhabdomyolysis.

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Explain the pathophysiology of rhabdomyolysis at the cellular level and discuss the resultant effects on organ systems.
  • Discuss the clinical presentation and management steps for patients with rhabdomyolysis.

Accreditation Statement

This activity has been reviewed and is approved for a maximum of 1.0 AAPA Category 1 CME credit by the PA Review Panel. Participants should only claim credit commensurate with their participation in the CME activity. This program was planned in accordance with AAPA’s CME Standards.

Disclosure Policy Statement

It is the policy of AAPA to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member has with the commercial interest of any commercial product discussed in an educational presentation. The participating faculty reported the following:

Courtney M. Boucher is a graduate of the primary care PA program at the University of Southern California (USC) in Alhambra, Calif. She practices emergency medicine in Temecula, Calif. Anne Walsh is an instructor of clinical family medicine at USC’s Keck School of Medicine and practices family medicine in Newport Beach, Calif. Christopher P. Forest is an assistant professor of clinical family medicine and director of research at USC’s primary care PA program in the Keck School of Medicine and practices urgent care and family medicine in Los Angeles, Calif. Henry Heard is an assistant clinical professor in the PA program at Mercer University in Atlanta, Ga. James Barker is on the hospitalist service at Emory Johns Creek Hospital in Johns Creek, Ga.The authors have disclosed no potential conflicts of interest, financial or otherwise.

AAPA offers no returns or refunds on online internet CME activities purchased through our store. All sales are final. Meeting and workshop registrations will be refunded in accordance with the cancellation policy of the meeting and/or workshop, as outlined at registration.



Type:     Journal-based CME
7213 Registered Users